These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28780080)

  • 1. "How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis.
    Roccatello D
    Autoimmun Rev; 2017 Oct; 16(10):995-998. PubMed ID: 28780080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.
    Marzano AV; Raimondo MG; Berti E; Meroni PL; Ingegnoli F
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):428-438. PubMed ID: 28578472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapies for ANCA-associated vasculitis.
    Lally L; Spiera R
    Annu Rev Med; 2015; 66():227-40. PubMed ID: 25341007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological drugs in ANCA-associated vasculitis.
    Lutalo PM; D'Cruz DP
    Int Immunopharmacol; 2015 Aug; 27(2):209-12. PubMed ID: 25907243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell-targeted therapy in systemic vasculitis.
    Lally L; Spiera R
    Curr Opin Rheumatol; 2016 Jan; 28(1):15-20. PubMed ID: 26599379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA-associated vasculitis in childhood: recent advances.
    Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
    Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis.
    Iannella G; Greco A; Granata G; Manno A; Pasquariello B; Angeletti D; Didona D; Magliulo G
    Autoimmun Rev; 2016 Jul; 15(7):621-31. PubMed ID: 26851550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: advances in pathogenesis and treatment].
    Silva F; Cisternas M
    Rev Med Chil; 2013 Jun; 141(6):765-73. PubMed ID: 24121580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study.
    Hollick RJ; James WRG; Nicoll A; Locock L; Black C; Dhaun N; Egan AC; Fluck N; Laidlaw L; Lanyon PC; Little MA; Luqmani RA; Moir L; McBain M; Basu N
    Lancet Rheumatol; 2024 Jun; 6(6):e361-e373. PubMed ID: 38782514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculitis for the internist: focus on ANCA-associated vasculitis.
    Chaigne B; Guillevin L
    Intern Emerg Med; 2017 Aug; 12(5):577-585. PubMed ID: 28623488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.
    Noone D; Hebert D; Licht C
    Pediatr Nephrol; 2018 Jan; 33(1):1-11. PubMed ID: 27596099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of pulmonary vasculitis.
    Yunt ZX; Frankel SK; Brown KK
    Ther Adv Respir Dis; 2012 Dec; 6(6):375-90. PubMed ID: 22878624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uptodate in the management and treatment of ANCA-associated vasculitis].
    Belaconi IN; Toma CL; Bogdan MA
    Pneumologia; 2014; 63(2):78-80, 83-6. PubMed ID: 25241554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.
    Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T
    Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of semaphorins in immune responses and autoimmune rheumatic diseases.
    Nishide M; Kumanogoh A
    Nat Rev Rheumatol; 2018 Jan; 14(1):19-31. PubMed ID: 29213125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.